Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/04/18 → 31/07/24 |
Funding
- National Institute for Health Research: £1,492,799.35
- National Institute for Health Research: £5,457.83
- National Institute for Health Research: £791,700.15
Alpha 2 Agonists for Sedation to produce Better Outcomes from Critical Illness (A2B TRIAL): A Parallel Group Randomised Controlled Trial Comparing Clonidine, Dexmedetomidine and Current Usual Care
- Walsh, Timothy (Principal Investigator)
- Walsh, Timothy (Principal Investigator)
- Lone, Nazir (Co-investigator)
- Maclullich, Alasdair (Co-investigator)
- Maclullich, Alasdair (Co-investigator)
- Norrie, John (Co-investigator)
- Norrie, John (Co-investigator)
- Parker, Richard (Co-investigator)
- Parker, Richard (Co-investigator)
- Weir, Christopher (Co-investigator)
- Weir, Christopher (Co-investigator)